32 research outputs found
Modified gravity without dark matter
On an empirical level, the most successful alternative to dark matter in
bound gravitational systems is the modified Newtonian dynamics, or MOND,
proposed by Milgrom. Here I discuss the attempts to formulate MOND as a
modification of General Relativity. I begin with a summary of the
phenomenological successes of MOND and then discuss the various covariant
theories that have been proposed as a basis for the idea. I show why these
proposals have led inevitably to a multi-field theory. I describe in some
detail TeVeS, the tensor-vector-scalar theory proposed by Bekenstein, and
discuss its successes and shortcomings. This lecture is primarily pedagogical
and directed to those with some, but not a deep, background in General
RelativityComment: 28 pages, 10 figures, lecture given at Third Aegean Summer School,
The Invisible Universe: Dark Matter and Dark Energy, minor errors corrected,
references update
Evaluating synergy between marbofloxacin and gentamicin in Pseudomonas aeruginosa strains isolated from dogs with otitis externa
The aim of this study was to determine antimicrobial susceptibility of Pseudomonas aeruginosa strains to marbofloxacin and gentamicin, and investigate the possible synergistic, additive, indifferent or antagonistic effects between the two agents. P. aeruginosa strains can develop resistance quickly against certain antibiotics if used alone, thus the need emerges to find synergistic combinations. A total of 68 P. aeruginosa strains isolated from dogs were examined. In order to describe interactions between marbofloxacin and gentamicin the checkerboard microdilution method was utilized. The MICs (minimum inhibitory concentrations) for marbofloxacin and gentamicin were in the range 0.25â64 mg/L and 0.25â32 mg/L, respectively. The combination of marbofloxacin and gentamicin was more effective with a MIC range of 0.031â8 mg/L and a MIC90 of 1 mg/L, compared to 16 mg/L for marbofloxacin alone and 8 mg/L for gentamicin alone. The FIC (fractional inhibitory concentration) indices ranged from 0.0945 (pronounced synergy) to 1.0625 (indifference). Synergy between marbofloxacin and gentamicin was found in 33 isolates. The mean FIC index is 0.546, which represents a partial synergistic/additive effect close to the full synergy threshold. In vitro results indicate that marbofloxacin and gentamicin as partially synergistic agents may prove clinically useful in combination therapy against P. aeruginosa infections. Although marbofloxacin is not used in the human practice, the interactions between fluoroquinolones and aminoglycosides may have importance outside the veterinary field